Takeda Pharmaceutical News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

14.10.22	Takeda: CHMP Recommends Approval Of Dengue Vaccine Candidate, TAK-003 (RTTNews)
05.10.22	Takeda: FDA Accepts SBLA For TAKHZYRO To Prevent Hereditary Angioedema Attacks In 2-12 Years (RTTNews)
20.09.22	Canada Oks Takeda' LIVTENCITY For Treatment Of Adults With Post-transplant Cytomegalovirus Infection (RTTNews)
16.09.22	Takeda: Maribavir Gets Positive CHMP Opinion To Treat Post-transplant Cytomegalovirus Refractory (RTTNews)
14.09.22	Takeda Launches CDPATH™, a Personalized Prognostic Tool, Advancing Innovation for Patients with Crohn's Disease (PR Newswire)
22.08.22	Indonesia Approves Takeda's Dengue Vaccine Qdenga (RTTNews)
21.07.22	Takeda's Hyqvia Phase 3 Trial In CIDP Patients Meets Primary Endpoint (RTTNews)
01.07.22	Takeda's Takhzyro Shows Positive Results In Prevention Of HAE Attacks In Phase 3 Study In Children (RTTNews)
09.06.22	Takeda: TAK-003 Shows 84.1% Vaccine Efficacy Against Hospitalized Dengue In Long-term TIDES Trial (RTTNews)
31.05.22	Takeda To Transfer Marketing Authorization For COVID-19 Vaccine In Japan To Moderna (RTTNews)
11.05.22	Takeda Pharma FY21 Core Profit Rises (RTTNews)
19.04.22	Takeda : Japan Approves Nuvaxovid COVID-19 Vaccine For Primary And Booster Immunization (RTTNews)
12.04.22	Takeda Pharma Says Phase 3 SHP643-301 Study Of Takhzyro Meets Objectives (RTTNews)
18.02.22	Takeda Presents Promising Initial Results From INSPIRE Study Of Alofisel (RTTNews)
31.01.22	Takeda : FDA Oks Prophylactic Treatment With Vonvendi For Adult Patients With Severe Type 3 VWD (RTTNews)
16.12.21	Novavax: Partner Takeda Submits NDA In Japan For Approval Of COVID-19 Vaccine (RTTNews)
25.11.21	FDA Approves Livtencity As First Drug To Treat Post-transplant Cytomegalovirus (RTTNews)
29.10.21	Biotech Stocks Facing FDA Decision In November 2021 (RTTNews)
08.10.21	Takeda: FDA Panel Supports Maribavir To Treat Post-Transplant Recipients With CMV Infection& Disease (RTTNews)
06.10.21	Takeda To Stop Phase 2 Studies Of Investigational Oral Orexin Agonist TAK-994 (RTTNews)
30.09.21	Takeda Reaches Agreement With JCR Pharma To Commercialize JR-141 Outside Of U.S. (RTTNews)
30.09.21	Biotech Stocks Facing FDA Decision In October 2021 (RTTNews)
21.09.21	Takeda Agrees With Mirum Pharma For Approval, Commercialization Of Maralixibat In Japan (RTTNews)
30.08.21	Japan To Probe Deaths After Shots From Suspended Moderna Vaccines (RTTNews)
02.08.21	Takeda To Record Provision Of 63 Bln Yen On Irish Tax Issue (RTTNews)
30.07.21	Takeda Pharma Q1 Profit Surges, Maintains FY Outlook - Quick Facts (RTTNews)
29.07.21	Takeda, Frazier Collaborate To Develop Clinical Stage Norovirus Vaccine Candidate (RTTNews)
20.07.21	Moderna To Supply Addl 50 Mln Doses Of COVID-19 Vaccine And Booster Vaccine To Japan (RTTNews)
16.06.21	Takeda Pharmaceuticals Marks its 240th Founding Anniversary (PR Newswire)
16.06.21	Takeda Pharmaceuticals Marks its 240th Founding Anniversary (PR Newswire)
09.06.21	Takeda introduces the In Their Shoes experience to the Middle East in support of the IBD patient community (PR Newswire)
09.06.21	Takeda introduces the In Their Shoes experience to the Middle East in support of the IBD patient community (PR Newswire)
21.05.21	Takeda Says FDA Grants Priority Review Of Maribavir For Treatment Of CMV Infection - Quick Facts (RTTNews)
21.05.21	Moderna's MRNA COVID-19 Vaccine Approved In Japan (RTTNews)
11.05.21	Takeda FY20 Profit Surges, Revenue Down; Sees Weak Profit, Higher Revenues In FY21 (RTTNews)
07.04.21	Kamada Amends GLASSIA License Agreement With Takeda - Quick Facts (RTTNews)
22.03.21	Evotec Reaches Multi-RNA Target Alliance With Takeda Pharma - Quick Facts (RTTNews)
18.03.21	Anima Biotech, Takeda Collaborate To Develop MRNA Translation Modulators For Neurological Diseases (RTTNews)
15.03.21	Takeda: Phase3 Trial Analysis Supports Efficacy Of Maribavir Over Therapies In Transplant Recipients (RTTNews)
15.03.21	Takeda Reaches Deal With IDT To Support Manufacturing Of Johnson & Johnson's COVID-19 Vaccine (RTTNews)
11.03.21	Takeda Aims Double-digit Revenue Growth In Growth & Emerging Markets Business Unit Over Next Decade (RTTNews)
05.03.21	Takeda Submits NDA To Import And Distribute Moderna's COVID-19 Vaccine Candidate In Japan (RTTNews)
04.03.21	KMPH Scores FDA Nod For ADHD Drug, MNOV Quits COVID-19 Vaccine Race, UTHR Gives Up On Trevyent (RTTNews)
02.03.21	Neurocrine Biosciences: Luvadaxistat Fails To Meet Primary Endpoint In Phase II INTERACT Study (RTTNews)
26.02.21	Takeda Pharma To Divest Portfolio Of Diabetes Products In Japan To Teijin Pharma (RTTNews)
24.02.21	Takeda Updates On Phase 1/2 Trials Of Novavax And Moderna's COVID-19 Vaccine Candidates In Japan (RTTNews)
12.02.21	Takeda Pharma: SOLSTICE Trial With Maribavir Meets Primary Endpoint - Quick Facts (RTTNews)
01.02.21	Takeda Closes EUR 350 Mln TachoSil Sale To Corza Health; Signs Long-term Manufacturing, Supply Deal (RTTNews)
21.01.21	Moderna Says First Participant Dosed In Phase 1/2 Study Of COVID-19 Vaccine In Japan (RTTNews)
08.01.21	Myriad Receives Reimbursement Decision For MyChoice Diagnostic System - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	71.14	1.54 %	K V
UBS Group	28.08	1.48 %	K V
Swiss Re	130.05	1.05 %	K V
Part Grp Hldg	1’266.00	0.96 %	K V
ABB	49.48	0.94 %	K V
Geberit	525.20	0.27 %	K V
Alcon	78.04	0.05 %	K V
Givaudan	3’868.00	-0.31 %	K V
CieFinRichemont	121.20	-0.57 %	K V
Sonova Hldg	301.00	-0.99 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Takeda Pharmaceutical Co Ltd. (spons. ADRs)

Aktien Top/Flop

Meistgelesene Nachrichten